Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Shenzhen YHLO Biotech Co., Ltd.

Shenzhen YHLO Biotech Co., Ltd. (YHLO) is an immunoassay solutions company that specializes in developing, manufactur... read more Featured Products: More products

Download Mobile App





YHLO Unveils Total Laboratory Automation System for Elevated Laboratory Efficiency

By LabMedica International staff writers
Posted on 05 Feb 2025

YHLO (Shenzhen, China) is presenting iTLA Max, its total laboratory automation system designed to enhance laboratory workflows and optimize performance. More...

YHLO's independently developed iTLA MAX laboratory automation system is designed to address practical issues in medical laboratories, integrating innovative technology into every aspect of laboratory work, from pre-analysis to analysis and post-analysis, achieving comprehensive intelligent connectivity. It plays a significant role in improving clinical laboratory testing efficiency, enhancing departmental management capabilities, and advancing the development of laboratory science. The iTLA MAX laboratory automation system is composed of units such as sampling, centrifugation, capping, rack connection, track, and output, offering unprecedented convenience and efficiency in sample processing through its intelligent and efficient modular design. The 360-degree ring light design ensures that laboratory personnel can observe the equipment's operating status from any angle, providing strong support for laboratory safety management. The waterfall-style screen design, combined with ergonomic standards, adjusts the screen height to ensure user comfort during operation. The intelligent information management system integrates multiple functions such as operation control, data processing, alarm prompts, and query statistics, providing laboratory personnel with an intuitive and convenient interface.

YHLO’s iFlash series chemiluminescence immunoassay analyzers, highly acclaimed in the industry for their exceptional accuracy and rapid processing speed, were prominently featured at the exhibition. In addition to its leading self-immunity diagnostic products, YHLO highlighted its new biochemistry-immunoassay integrated analyzer along with a comprehensive suite of over 100 testing assays. As a major player in China’s IVD industry, YHLO offers a wide array of testing solutions covering self-immunity, infectious disease, reproductive health, liver disease, respiratory conditions, and cardiovascular diagnostics, among others. The new integrated analyzer provides laboratories with more flexible testing options.


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Gold Member
Automated MALDI-TOF MS System
EXS 3000
New
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Microbiology

view channel
Image: Development of targeted therapeutics and diagnostics for extrapulmonary tuberculosis at University Hospital Cologne (Photo courtesy of Michael Wodak/Uniklinik Köln)

Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis

Extrapulmonary tuberculosis (EPTB) remains difficult to diagnose and treat because it spreads beyond the lungs and lacks easily accessible biomarkers. Despite TB infecting 10 million people yearly, the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.